Cargando…

Preferred and actual place of death in haematological malignancy

OBJECTIVES: Home is considered the preferred place of death for many, but patients with haematological malignancies (leukaemias, lymphomas and myeloma) die in hospital more often than those with other cancers and the reasons for this are not wholly understood. We examined preferred and actual place...

Descripción completa

Detalles Bibliográficos
Autores principales:	Howell, D A, Wang, H I, Roman, E, Smith, A G, Patmore, R, Johnson, M J, Garry, A, Howard, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502252/ https://www.ncbi.nlm.nih.gov/pubmed/26156005 http://dx.doi.org/10.1136/bmjspcare-2014-000793

Ejemplares similares

Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network
por: Sheridan, Rebecca, et al.
Publicado: (2021)

Perspectives of bereaved relatives of patients with haematological malignancies concerning preferred place of care and death: A qualitative study
por: McCaughan, Dorothy, et al.
Publicado: (2019)

Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy
por: Howell, Debra A, et al.
Publicado: (2010)

Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death
por: Howell, Debra A, et al.
Publicado: (2013)

Haematology nurses' perspectives of their patients' places of care and death: A UK qualitative interview study
por: McCaughan, Dorothy, et al.
Publicado: (2019)

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2011)

Determinants of hospital death in haematological cancers: findings from a qualitative study
por: McCaughan, Dorothy, et al.
Publicado: (2018)

Hodgkin lymphoma detection and survival: findings from the Haematological Malignancy Research Network
por: Lamb, Maxine JE, et al.
Publicado: (2019)

Experiences and preferences for psychosocial support: a qualitative study exploring the views of patients with chronic haematological cancers
por: Sheridan, Rebecca, et al.
Publicado: (2023)

Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network
por: Howell, Debra A, et al.
Publicado: (2013)

Palliative care specialists’ perceptions concerning referral of haematology patients to their services: findings from a qualitative study
por: McCaughan, Dorothy, et al.
Publicado: (2018)

Incurable but treatable: Understanding, uncertainty and impact in chronic blood cancers—A qualitative study from the UK’s Haematological Malignancy Research Network
por: Howell, Debra A., et al.
Publicado: (2022)

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research
por: Smith, Alexandra, et al.
Publicado: (2010)

Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN)
por: Smith, Alexandra, et al.
Publicado: (2018)

Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2015)

Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts
por: Roman, Eve, et al.
Publicado: (2022)

Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network
por: Kane, Eleanor, et al.
Publicado: (2017)

Family Preference for Place of Death Mediates the Relationship between Patient Preference and Actual Place of Death: A Nationwide Retrospective Cross-Sectional Study
por: Ishikawa, Yoshiki, et al.
Publicado: (2013)

Treatment decision making (TDM): a qualitative study exploring the perspectives of patients with chronic haematological cancers
por: McCaughan, Dorothy, et al.
Publicado: (2022)

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort
por: Smith, Alexandra, et al.
Publicado: (2018)

The Hospice Information System and its association with the congruence between the preferred and actual place of death
por: Lin, Huang-Ren, et al.
Publicado: (2017)

Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15
por: Roman, Eve, et al.
Publicado: (2016)

Preference of the Place of Death
por: Tin, SimSai, et al.
Publicado: (2015)

Variations in specialist palliative care referrals: findings from a population-based patient cohort of acute myeloid leukaemia, diffuse large B-cell lymphoma and myeloma
por: Howell, D A, et al.
Publicado: (2015)

Actual and Preferred Place of Death of Home-Dwelling Patients in Four European Countries: Making Sense of Quality Indicators
por: De Roo, Maaike L., et al.
Publicado: (2014)

The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK’s population-based Haematological Malignancy Research Network
por: Kane, Eleanor, et al.
Publicado: (2019)

Risk of mature B‐cell neoplasms and precursor conditions after joint replacement: A report from the Haematological Malignancy Research Network
por: Kane, Eleanor, et al.
Publicado: (2019)

Preference of the Place of Death Among People of Pune
por: Kulkarni, Priyadarshini, et al.
Publicado: (2014)

Clinical use of rituximab in haematological malignancies
por: Avivi, I, et al.
Publicado: (2003)

Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network
por: Crouch, Simon, et al.
Publicado: (2022)

Outcome of patients with haematological malignancy admitted to the general ICU
por: Ketchley, I, et al.
Publicado: (2008)

Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction
por: Howell, S J, et al.
Publicado: (2000)

Patients’ preferred place of death: patients are willing to consider their preferences, but someone has to ask them
por: van Doorne, Iris, et al.
Publicado: (2021)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

COVID-19 in children with haematological malignancies
por: Millen, Gerard Cathal, et al.
Publicado: (2022)

Death: Legal and Actual
por: Danforth, I. N.
Publicado: (1871)

Is intensive care beneficial for patients with haematologic malignancies?
por: Nyunga, M, et al.
Publicado: (2010)

PSYCHOLOGICAL ASPECTS OF HAEMATOLOGICAL MALIGNANCIES
por: Kulhara, P., et al.
Publicado: (1990)

Tuberculosis in Patients with Haematological Malignancies
por: Anibarro, Luis, et al.
Publicado: (2014)

Expression of testicular genes in haematological malignancies
por: Lim, S H, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_qrljln2pbtkb1u073v177u70uo